Stefanizzi P, Moscara L, Palmieri C, Martinelli A, et al. Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021-23. Vaccine 2024 Apr 5:S0264-410X(24)00311-6. doi: 10.1016/j.vaccine.2024.
PMID: 38582693